4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001176
SVP, Treasurer & CAO sold 21,570 shares at $4.55 ($98,144)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lafond Kevin G SVP, Treasurer & CAO | 2020-01-02 | Sale | −21,570 | $4.55 | $98,144 | 63,985 | D |
| Derivatives | |||||||
| Lafond Kevin G SVP, Treasurer & CAO | 2019-12-31 | Grant or award · Employee Stock Option (right to buy) | +48,000 | 48,000 | D | ||
| Open-market sales · 21,570 sh · avg $4.55 · $98,144 | |||||||
Loading xslF345X03/doc4.xml…